Worldwide Variability of Antithrombotic Therapy During Cardiac Catheter Ablation in Children: A Survey from 50 Centers Around the World
- 17 Downloads
Although electrophysiological studies and cardiac catheter ablation are rare procedures in children, their use has increased during the last decades . These procedures have a thrombotic risk . Guidelines for the prevention of thrombotic events following radiofrequency (RF) catheter ablation are available [1, 3]. However, there is an absence of high-quality evidence in this setting.
A web-based survey regarding prevention and management of thrombotic complications during electrophysiology studies and cardiac catheter ablation procedures in children was designed in order to determine current practice worldwide.
Fifty surveys were returned from 50 centers. Of them, thirty-two had performed more than 20 procedures in children during the previous 3 months. Surveys were filled by pediatric cardiologists (62.5%), cardiologists (24%), and electrophysiologists (12%) from Europe (n = 24) and America (n = 16) mainly. Apart from the results shown in Table 1, it is remarkable that 92% of the...
Compliance with Ethical Standards
Conflict of interest
This article did not receive any funding. Authors do not have any conflict of interest. This article does not contain any studies with human participants performed by any of the authors.
- 1.Blanc JJ, Almendral J, Brignole M, Fatemi M, Gjesdal K, González-Torrecilla E, Kulakowski P, Lip GY, Shah D, Wolpert C, Scientific Initiatives Committee of the European Heart Rhythm Association (2008) Consensus document on antithrombotic therapy in the setting of electrophysiological procedures. Europace 10:513–527CrossRefGoogle Scholar
- 2.Kugler JD, Danford DA, Houston KA, Felix G, Pediatric Radiofrequency Ablation Registry of the Pediatric Radiofrequency Ablation Registry of the Pediatric Electrophysiology Society (2002) Pediatric radiofrequency catheter ablation registry success, fluoroscopy time, and complication rate for supraventricular tachycardia: comparison of early and recent eras. J Cardiovasc Electrophysiol 13:336–341CrossRefGoogle Scholar
- 3.Giglia TM, Massicotte MP, Tweddell JS, American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Stroke Council et al (2013) Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation 128:2622–2703CrossRefGoogle Scholar
- 9.Monagle P, Chan AK, Goldengerg NA, Ichord RN, Journeycake JM, Nowak-Göttl U, Vesely SK, American College of Chest Physicians (2012) Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e737S–e810SCrossRefGoogle Scholar